Redica Systems, Inc.

Founded in 2010, and based in California, US, Redica Systems, Inc. , formerly known as Govzilla, operates as a software company that operates a cloud-based quality and regulatory intelligence (QRI) platform. FDAzilla was the original name of the company, however, it was renamed to Govzilla in 2017. In 2020, the company renamed itself Redica Systems, Inc, and launched a new version of its enforcement analytics platform for customers.

As of 2021, the company’s CEO is Michael de la Torre, and it has a client base of over 200 customers. In April 2025, Redica Systems, Inc. raised USD 15 million in venture debt funding from returning investor CIBC Innovation Banking. Redica Systems runs a cloud-based quality and regulatory intelligence platform that employs artificial intelligence to give insights and analytics to FDA-regulated sectors in order to help them make compliance and regulatory decisions.

The platform is also used by quality and safety specialists to uncover compliance and risk issues in their company's day-to-day operations, such as inaccurate datasets, ineffective technology, and non-regulatory manual procedures. The company’s client base includes companies in the pharma, medical devices, cosmetics, and food sectors such as Genentech, MERCK, Zoetis, Amgen, and Mary Kay. The company plans to utilize the April 2025 funding to increase the range of products it offers.